跳至主要内容
临床试验/NCT04299438
NCT04299438终止3 期

Propranolol Rescue of Prolonged Labor (PROPEL): A Randomized, Double-blind, Placebo-controlled Multicenter Investigation of Propranolol's Effect on Cesarean Delivery Rate Among Women With Prolonged Labor

Lisa Levine2 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2020年7月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
164
试验地点
2
主要终点
Mode of Delivery

研究概览

简要总结

A double-blind placebo controlled randomized trial comparing cesarean delivery rates in women given IV propranolol versus placebo for treatment of prolonged labor.

详细描述

A double-blind placebo controlled randomized trial comparing cesarean delivery rates in 326 women given IV propranolol (2 mg with one possible repeat dose greater than 2 hours later) versus IV placebo for treatment of prolonged labor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • English-speaking
  • >= 36 weeks gestation
  • Singleton pregnancy
  • Vertex presentation
  • No contraindication to a vaginal delivery
  • Meets at least one study criteria for prolonged labor:
  • cervical dilation <6 cm after ≥8 hours with ruptured membranes and receiving oxytocin OR
  • cervical dilation >=6 cm and <1 cm dilation change over ≥2 hours with ruptured membranes and receiving oxytocin

排除标准

  • Severe preeclampsia: as patients will be receiving magnesium and possibly labetalol for hypertension control
  • Receiving other beta blocker
  • Maternal heart rate < 70 beats per minute, systolic blood pressure <90 mmHg, or diastolic blood pressure <50 mmHg on two sets of vital signs in the 1 hour prior to study drug administration: given that bradycardia and hypotension are possible side effects of propranolol
  • History of any form of asthma: as this is a contraindication to beta blocker use
  • Diabetes requiring insulin in labor: given the potential risk of neonatal hypoglycemia in the neonate
  • Any cardiac condition for which β blockade is contraindicated (cardiogenic shock, sinus bradycardia, and greater than first degree heart block)
  • Known hypersensitivity to propranolol
  • Intrauterine fetal demise since different labor protocols are used in these women
  • Major fetal congenital anomaly since rate of cesarean may be inherently different in these women, unrelated to labor

研究组 & 干预措施

Propranolol

Active Comparator

IV Propranolol - 2mg; one possible repeat dose ≥2 hours later

干预措施: Propranolol Hydrochloride (Drug)

Placebo

Placebo Comparator

Normal saline placebo- 2 mL; one possible repeat dose ≥2 hours later

干预措施: Saline (Other)

结局指标

主要结局

Mode of Delivery

时间窗: From enrollment into the trial until delivery.

Number of participants with a cesarean delivery

次要结局

  • Maternal Morbidity(from delivery through 4 weeks postpartum)
  • Neonatal Morbidity(from delivery through hospital discharge, usually 2-4 days)
  • Postpartum Hemorrhage(from time of delivery through hospital discharge, usually 2-4 days)
  • Length of Labor(hours from start of labor or induction of labor to time of delivery)
  • Chorioamnionitis(from start of labor through delivery)

研究者

发起方
Lisa Levine
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lisa Levine

Assistant Professor of Obstetrics and Gynecology

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验